Under construction – not a live service
Sign in
Not yet taking people in LatviaNo phase

Adapting the Home to Support Stroke Rehabilitation

Tests a home-setup approach to rehabilitation in adults recovering from stroke.

Plain-language title generated from the registry record
Registry title: Home-Based Stroke Rehabilitation Using Enriched Environments (PEER-HOMEcare)

Key facts

Where
Riga, LatviaSee the site

Where in Latvia

  • Riga Stradins University HospitalRiga, LatviaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Norwegian School of Sport Sciences
Trial code
NCT07517120
Record updated
8 April 2026
Original description
The goal of this clinical trial is to learn whether the PEERHOMEcare intervention is a feasible and acceptable methodology that may have the potential to improve recovery for adults who are recovering from stroke and receiving rehabilitation at home. PEERHOMEcare adapts research on enriched environments to support brain recovery by creating stimulating and supportive home rehabilitation settings and by involving healthcare professionals and family members. The main questions it aims to answer are whether the PEERHOMEcare approach is feasible to implement in home-based stroke rehabilitation in Norway, Sweden, and Latvia, and whether it improves patient engagement and participation in rehabilitation during the first six months after stroke. Researchers will assess the delivery of the PEERHOMEcare approach to see if the intervention is feasible and acceptable and if the educational material can be used to improve engagement and recovery. Participants will receive home-based stroke rehabilitation, work with project therapists and family members to adapt their home environment to support rehabilitation activities, and complete assessments and follow-up visits to measure engagement, upper limb motor recovery, and feasibility of the intervention.Read full original descriptionShow less

Pedagogy and Enriched Environment for Rehabilitation in the Home After Stroke (PEER-HOMEcare): Study Protocol for a Single-Group Feasibility Study

The goal of this clinical trial is to learn whether the PEERHOMEcare intervention is a feasible and acceptable methodology that may have the potential to improve recovery for adults who are recovering from stroke and receiving rehabilitation at home. PEERHOMEcare adapts research on enriched environments to support brain recovery by creating stimulating and supportive home rehabilitation settings and by involving healthcare professionals and family members. The main questions it aims to answer are whether the PEERHOMEcare approach is feasible to implement in home-based stroke rehabilitation in Norway, Sweden, and Latvia, and whether it improves patient engagement and participation in rehabilitation during the first six months after stroke. Researchers will assess the delivery of the PEERHOMEcare approach to see if the intervention is feasible and acceptable and if the educational material can be used to improve engagement and recovery. Participants will receive home-based stroke rehabilitation, work with project therapists and family members to adapt their home environment to support rehabilitation activities, and complete assessments and follow-up visits to measure engagement, upper limb motor recovery, and feasibility of the intervention.

Inclusion: adults (≥18 years old); diagnosed with first or second haemorrhagic or ischaemic stroke; stroke onset no more than six months before study enrolment; discharged to their home following inpatient rehabilitation; reporting functional impairments in the upper extremity that affect functioning and participation in everyday life due to the latest stroke; score at least 4 points on the Shoulder Abduction + Finger Extension (SAFE) measure; adequate language skills and cognitive functioning to be able to understand intervention material, perform outcome assessments and co-operate throughout the intervention; willing to participate and able to provide written consent; consent for participation also by closest family members, if they live in the same household.

Exclusion: presence of other neurological conditions; reported limited life expectancy due to other medical conditions during the study period; severe mental health disorders, including substance use disorders; a history of violence; uncontrolled medical issues such as unstable angina, severe hypertension, or severely limiting orthopaedic conditions; severe communication and/or cognition deficits (MoCA below 10 points) that prevent participants from being able to participate in the intervention, understand interview questions, or study-related instructions; unwillingness of persons sharing the household to participate and accept the intervention.

ClinicalTrials.gov NCT07517120